These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 31150423

  • 1. Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma.
    Spaggiari D, Desfontaine V, Cruchon S, Guinchard S, Vocat A, Blattes E, Pitteloud J, Ciullini L, Bardinet C, Ivanyuk A, Makarov V, Ryabova O, Buclin T, Cole ST, Decosterd LA.
    PLoS One; 2019; 14(5):e0217139. PubMed ID: 31150423
    [Abstract] [Full Text] [Related]

  • 2. Optimized LC-MS/MS quantification of tuberculosis drug candidate macozinone (PBTZ169), its dearomatized Meisenheimer Complex and other metabolites, in human plasma and urine.
    Desfontaine V, Guinchard S, Marques S, Vocat A, Moulfi F, Versace F, Huser-Pitteloud J, Ivanyuk A, Bardinet C, Makarov V, Ryabova O, André P, Prod'Hom S, Chtioui H, Buclin T, Cole ST, Decosterd L.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan 15; 1215():123555. PubMed ID: 36563654
    [Abstract] [Full Text] [Related]

  • 3. A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
    Mercier T, Desfontaine V, Cruchon S, Da Silva Pereira Clara JA, Briki M, Mazza-Stalder J, Kajkus A, Burger R, Suttels V, Buclin T, Opota O, Koehler N, Sanchez Carballo PM, Lange C, André P, Decosterd LA, Choong E.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov 15; 1211():123456. PubMed ID: 36240540
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169)].
    Mariandyshev AO, Khokhlov AL, Smerdin SV, Shcherbakova VS, Igumnova OV, Ozerova IV, Bolgarina AA, Nikitina NA.
    Ter Arkh; 2020 Apr 27; 92(3):61-72. PubMed ID: 32598795
    [Abstract] [Full Text] [Related]

  • 7. Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV.
    Courlet P, Alves Saldanha S, Cavassini M, Marzolini C, Choong E, Csajka C, Günthard HF, André P, Buclin T, Desfontaine V, Decosterd LA.
    J Mass Spectrom; 2020 Jun 27; 55(6):e4506. PubMed ID: 32160389
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development and validation of LC-ESI-MS/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosis.
    Lee SJ, Desta KT, Eum SY, Dartois V, Cho SN, Bae DW, Shin SC.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan 15; 1009-1010():138-43. PubMed ID: 26730550
    [Abstract] [Full Text] [Related]

  • 10. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
    He G, Guo B, Zhang J, Li Y, Wu X, Fan Y, Chen Y, Cao G, Yu J.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr 01; 1081-1082():87-100. PubMed ID: 29518721
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Determination of the active and inactive metabolites of prasugrel in human plasma by liquid chromatography/tandem mass spectrometry.
    Farid NA, McIntosh M, Garofolo F, Wong E, Shwajch A, Kennedy M, Young M, Sarkar P, Kawabata K, Takahashi M, Pang H.
    Rapid Commun Mass Spectrom; 2007 Apr 01; 21(2):169-79. PubMed ID: 17154350
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development, Validation, and Clinical Application of an Ultra-High-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry Method for the Determination of 10 Antituberculosis Drugs in Human Serum.
    Fan X, Guo S, Zhang R, Cai Q, Lang Y, Huang J, Chen Y, Zhang Y, Xu Y, Chen M, Yang G, Cai X.
    Ther Drug Monit; 2024 Aug 01; 46(4):477-484. PubMed ID: 38287894
    [Abstract] [Full Text] [Related]

  • 19. Development and validation of a UHPLC-MS/MS method to measure cefotaxime and metabolite desacetylcefotaxime in blood plasma: a pilot study suitable for capillary microsampling in critically ill children.
    Guerra Valero YC, Dorofaeff T, Roberts JA, Lipman J, Coulthard MG, Sparkes L, Wallis SC, Parker SL.
    Anal Bioanal Chem; 2021 Jul 01; 413(17):4483-4491. PubMed ID: 34041575
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.